Ritter Pharmaceuticals (RTTR) Reports Q2 Loss of $0.48/Share

August 8, 2016 8:36 AM EDT
Get Alerts RTTR Hot Sheet
Trade RTTR Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Ritter Pharmaceuticals (NASDAQ: RTTR) reported Q2 EPS of ($0.48), versus ($4.18) reported last year.

For earnings history and earnings-related data on Ritter Pharmaceuticals (RTTR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment